- Other IMP or virus challenges: Receipt of any investigational drug within 3 months prior inoculation. Receipt of more than 4 investigational drugs within the previous 12 months. Prior participation in a clinical trial with same strain of respiratory virus. Participation in other respiratory virus challenge within 1 year prior to challenge